Gain Therapeutics, Inc. (GANX)
2.43
-0.32
(-11.64%)
USD |
NASDAQ |
Mar 13, 16:00
2.47
+0.04
(+1.65%)
Pre-Market: 09:00
Gain Therapeutics Shareholders Equity (Quarterly) : 5.909M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Agenus, Inc. | -274.14M |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 203.13M |
| Arrowhead Pharmaceuticals, Inc. | 568.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.97M |
| Total Liabilities (Quarterly) | 5.062M |
| Debt to Equity Ratio | 0.1024 |
| Current Ratio | 2.522 |
| Net Debt Paydown Yield | 0.06% |